Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Basilea Pharmaceutica develops antibacterial activity enhancers

Dec. 30, 2016

Hangzhou Innogate Pharma describes SYK/HDAC inhibitors

Dec. 30, 2016

Femtogenix discloses anticancer agents

Dec. 30, 2016

East China University of Science and Technology patents HER1 inhibitors

Dec. 30, 2016

Chiesi Farmaceutici presents muscarinic M3 receptor antagonists and beta2-adrenoceptor agonists

Dec. 29, 2016

Dana-Farber Cancer Institute develops SMO receptor antagonists

Dec. 29, 2016

Syros Pharmaceuticals describes c-Myc inhibitors

Dec. 29, 2016

Medshine Discovery discloses JAK inhibitors

Dec. 29, 2016

Vertex Pharmaceuticals patents triazoles for demyelinating diseases

Dec. 29, 2016

Merck & Co. and MSD R&D disclose PDE2A inhibitors

Dec. 28, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026